Raphael Pharmaceutical Inc. (RAPH)
OTCMKTS · Delayed Price · Currency is USD
0.7500
+0.5300 (240.91%)
At close: Jun 25, 2025
Raphael Pharmaceutical Company Description
Raphael Pharmaceutical Inc., a pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids.
The company develops lead product candidate for the treatment of rheumatoid arthritis. It also intends to develop cannabinoid-based drug products for the treatment of oncology indications and other autoimmune diseases.
The company is headquartered in Tel Aviv-Jaffa, Israel.
Raphael Pharmaceutical Inc.
| Country | United States |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Shlomo Pilo |
Contact Details
Address: 4 Lui Paster Jaffa, Nevada 6803605 Israel | |
| Phone | 972 5 2775 5072 |
| Website | raphaelpharmaceutical.com |
Stock Details
| Ticker Symbol | RAPH |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US27785B2088 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Shlomo Pilo | Chief Executive Officer and Director |
| Guy Ofir | General Counsel, Chief Financial Officer and Director |
| Dr. Igal Louria Hayon | Chief Technology Officer and Director |